Biography

Bill Reiland is a Managing Director and Chief Investment Officer of North Haven Expansion Credit and a Managing Director of Morgan Stanley based in New York. Over the course of his 35 years of experience, Mr. Reiland has invested, structured, and marketed over 100 credit and equity transactions representing over $10Bn. Mr. Reiland initially joined Morgan Stanley in 1993 and became Head of Morgan Stanley’s Global High Yield Debt Research department in 2001. Mr. Reiland was ranked as the top health care high-yield research analyst by Institutional Investor in 2000, 2001 and 2002. In 2006, Mr. Reiland joined MSPI where he led and executed private investments on behalf of Morgan Stanley. Mr. Reiland led investments in several of MSPI’s most successful investments, including JHP Pharmaceuticals and Grifols SA. In 2008, Mr. Reiland left Morgan Stanley and joined Leerink Swann, where he was responsible for originating, structuring and marketing debt securities. In 2013, Mr. Reiland became a partner at Oberland Capital Management, a structured fixed income and equity royalty fund. Mr. Reiland rejoined Morgan Stanley in 2014 to lead the North Haven Expansion Credit effort. Mr. Reiland’s experience also includes time at Bain & Co., Stanford Hospital, Cowen and Co., and Stifel Nicholas. Mr. Reiland graduated with a B.A. in Economics from Yale University and an MBA, with distinction, from the Tuck School of Graduate Business Administration, where he was a Tuck Scholar.
 
 
Bill is a member of the Morgan Stanley Expansion Capital
 
 
 

Puede no representar a todos los miembros del equipo.


La información incluida en esta página solo tiene fines informativos. Su objetivo es beneficiar a emisores terceros y a aquellos que buscan información sobre estrategias de inversión alternativa. La información que contiene no constituye una oferta de servicios de asesoramiento ni una oferta de venta o solicitud de oferta de compra de cualquier título en cualquier jurisdicción en la que dicha oferta o solicitud, compra o venta sea ilegal conforme a las leyes de valores, seguros u otras de dicha jurisdicción, y no debe interpretarse como tal.


Todas las inversiones entrañan riesgos, incluida la pérdida de principal. Las inversiones alternativas son especulativas e implican un alto grado de riesgo. Estas inversiones están diseñadas para inversores que entienden estos riesgos y están dispuestos a aceptarlos. La rentabilidad puede ser volátil y los inversores pueden perder la totalidad o una parte sustancial de su inversión.


Para conocer información importante sobre la estrategia, incluidas consideraciones adicionales sobre riesgos, consulte la página de datos de la estrategia.

 

Esta es una comunicación con fines comerciales.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.


Privacy & Cookies    •    Condiciones de uso

©  Morgan Stanley. All rights reserved.